NCT01064024View on ClinicalTrials.gov

Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
PainUrinary Tract Infections
Interventions
DRUG

Phenazopyridine Hydrochloride

Tablets, 200 mg, every 8 hours for 48 hours.

DRUG

Placebo

Tablets, every 8 hours for 48 hours

Trial Locations (1)

07512

Oxford Pharmaceutical Resources, Inc., Totowa

Sponsors

Collaborators (1)

Biostudy Solutions, LLC
All Listed Sponsors
collaborator

Oxford Pharmaceutical Resources, Inc.

INDUSTRY

collaborator

Sristek Clinical Research Solutions Limited

INDUSTRY

collaborator

Biostudy Solutions, LLC

UNKNOWN

lead

Amneal Pharmaceuticals, LLC

INDUSTRY